Latest filing published 23 May 2024 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
David Roland Walker Jayne: trading record in brief
All filings by David Roland Walker Jayne on record concern Aurinia Pharmaceuticals Inc. We count 8 filings; the first trade dates from 26 May 2015 and the latest from 21 May 2024.
The open-market side counts 1 purchase for €27k alongside 1 sale for €68k. On balance, insiders were net sellers of €41k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 option exercises.
On 23 May 2024 came the latest disclosure, an option exercise in Aurinia Pharmaceuticals Inc. The last purchase on record was published on 11 July 2022, which is 1,583 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Roland Walker Jayne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,364 sharesCommon SharesTSXSEDI:4318032
- 8,733 sharesCommon SharesTSXSEDI:4132941
- 8,733 shares@ CA$11.2654.3% of flowCommon SharesTSXSEDI:4132943
- 10,000 shares@ CA$3.62Common SharesTSXSEDI:3976679Canonical exit: 16 Aug 2022 (T+90)
- 10,000 shares@ CA$3.96Common SharesTSXSEDI:3651911
- 16,200 shares@ CA$4.3136.8% of flowCommon SharesTSXSEDI:3553822
- Common SharesTSXSEDI:3396410
- 3,800 shares@ CA$4.31100.0% of flowCommon SharesTSXSEDI:3396412
8 of 8 declarations
